Overview of benefit/risk of biological agents.

Imperato, A K; Bingham, C O; Abramson, S B

Imperato, A K; Bingham, C O; Abramson, S B.

Affiliation

Imperato AK; Department of Rheumatology/Medicine, Hospital for Joint Diseases, New York University, 301 East 17th Street, New York, New York 10003, USA.

Clin Exp Rheumatol ; 22(5 Suppl 35): S108-14, 2004.

Article in En | MEDLINE | ID: mdl-15552523

Subject(s)

Antirheumatic Agents/adverse effects; Arthritis, Rheumatoid/therapy; Sialoglycoproteins/adverse effects; Arthritis, Rheumatoid/epidemiology; Humans; Incidence; Interleukin 1 Receptor Antagonist Protein; Lupus Erythematosus, Systemic/epidemiology; Lupus Erythematosus, Systemic/etiology; Lymphoma/epidemiology; Lymphoma/etiology; Opportunistic Infections/epidemiology; Opportunistic Infections/etiology; Risk Assessment

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Sialoglycoproteins / Antirheumatic Agents Type of study: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Exp Rheumatol Year: 2004 Document type: Article Affiliation country: United States Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links